Kantipur Pharmaceuticals Lab to Issue IPO | Appoints Muktinath Capital as Issue Manager
September 4, 2024 | Investopaper
Kantipur Pharmaceuticals Lab Limited is in the process of issuing shares to the public (IPO). For this purpose, the company has appointed Muktinath Capital Limited as the issue and sales manager.
An agreement has been reached between the company and Muktinath Capital on this regard. The agreement was signed by Nawaraj Paudyal, of Kantipur Pharmaceuticals Lab and Kavindradhwaj Joshi, Chief Executive Officer of Muktinath Capital.
Now, the company needs to submit the application to the Securities Board Of Nepal (SEBON) after completing the necessary procedures. Only after the approval from the regulatory body SEBON, the company can sell shares to the public.
The company plans to sell 11,00,000 shares in the public offering.
About Kantipur Pharmaceuticals Lab Limited
Kantipur Pharmaceuticals Lab Limited, established in 2073 B.S, is involved in the research, production and planned marketing of veterinary allopathic medicines, animal nutrition, animal feed additives, Phyto feed additives and animal health products in accordance with GMP compliances.
Recommended:
